POSTER SESSION I
Monday, February 13, 2006   9:30 AM - 12:00 Noon
Chemokine Receptor CXCR4 (Fusin) Is A Poor Prognostic Factor In Diffuse Large B-Cell Lymphoma
MS Almiski, F Khanani, O Basturk, VN Adsay, MO Kurrer, E Levi - Harper Hospital, Wayne State University, John D Dingell VamC, Detroit, MI; University Hospital, Zurich, Switzerland
Detection of CD4, CD25, and CD152: A New Role for Flow Cytometry in the Diagnosis of Hodgkin Lymphoma?
DS Bosler, VK Douglas-Nikitin, MD Smith - William Beaumont Hospital, Royal Oak, MI
Clinical Implications of Quantitative and Qualitative Post-treatment Detection of amL1-ETO in amL
L Chen, J Guo, D Jones, R Luthra, P Lin - The University of Texas MD Anderson Cancer Center, Houston, TX
The Architectural Pattern of FOXP3+ T Cells Is an Independent Predictor of Survival in Patients with Follicular Lymphoma (FL)
P Farinha, E Campo, A Banham, H Masoudi, B Skinnider, JM Connors, K Shumansky, J Spinelli, RD Gascoyne - BC Cancer Agency, Vancouver, BC, Canada; Hospital Clinic, Barcelona, Spain; John Radcliffe Hospital, Oxford, United Kingdom; BCCA; BCCA, Canada
Simultaneous JAK2 V617F and KIT D816V Mutations in Systemic Mastocytosis
CD Galderisi, CL Corless, J Wolford, T Harrell, MC Heinrich, RD Press - Oregon Health and Science University, Portland, OR
Expression of B-cell Transcription Factors in Acute Myeloid Leukemia
SE Gibson, ED Hsi - Cleveland Clinic Foundation, Cleveland, OH
Non-Hodgkin Lymphoma Showing Abnormalities Of C-Myc Including Dual Translocations Involving C-Myc And Bcl2: A Clinicopathologic Study.
R Jastania, V Kukreti, K Chun, M Al Shraim, D Bailey, B Patterson, M Crump, S Boerner, W Geddie - University Health Network, Toronto, ON, Canada
Mixed Lineage Kinase-3 (MLK3) Expression Is A Poor Prognostic Factor In Diffuse Large B-Cell Lymphoma, Associated With An Activated B-Cell Subtype
F Khanani, MS Almiski, O Basturk, J Frank, MO Kurrer, E Levi - Harper Hospital, Wayne State University, John D Dingell VamC, Detroit, MI; University Hospital, Zurich, Switzerland
Frequency Of BCL2 Breakpoints In Follicular Lymphoma And Correlation With Histologic Grade
MR Mariappan, C Shum, DA Arber - Stanford University Medical Center, Stanford, CA
JAK2 V617 Mutational Analysis For The Diagnostic Work-Up Of Chronic Myeloproliferative Disorders.
C McMahon, JA Kant, FE Craig, SH Swerdlow, SA Monaghan - University of Pittsburgh School of Medicine, Pittsburgh, PA
Prognostic Significance of Bcl-2 and Bcl-6 Expression in Patients with Nodular Sclerosis Hodgkin Lymphoma (NSHL)
H Naushad, P Aoun, LM Smith, Z Pan, P Bierman, TC Greiner, WC Chan, DD Weisenburger - University of Nebraska Medical Center, Omaha, NE
Co-expression of CD15 and CD30 in Anaplastic Large Cell Lymphoma
V Neppalli, K Fu, WC Chan, TC Greiner, DD Weisenburger, P Aoun - University of Nebraska Medical Center, Omaha, NE
Development Of A Real Time PCR Assay For The JAK2 V617F Mutation In Myeloproliferative Disorders
RJ Olsen, D Tang, DW Bernard, DH Farkas, JCC Chang - Baylor College of Medicine, The Methodist Hospital, Houston, TX; Cornell University, Ithica, NY
Polymorphisms Affecting The Expression Of Certain Cytokines Associate With The Myelodysplastic Syndromes
MP Powers, A Raza, H Nishino, Y Lou, CC Chang - The Methodist Hospital and Weill Cornell Medical School, University of Houston, BCM, Houston, TX
Phenotypic Analysis Of T Cell Acute Lymphoblastic Leukemias With Genetic Alteration Of The TAL1 Locus
ER Rudzinski, Q Wang, S Olsen, MA Thompson - Vanderbilt University Medical Center, Nashville, TN
CD30 Positive Cells In Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL): A Clinicopathologic Evaluation.
RM Seliem, WL Wang, RP Hasserjian, JA Ferry, NL Harris, LR Zukerberg - Massachusetts General Hospital, Boston, MA
Appropriate Categorization Of High Grade B-Cell Lymphomas With Classical Burkitt Morphology But Lacking MYC Translocation.
DW Sevilla, JZ Gong, BK Goodman, PJ Buckley, AS Lagoo - Duke University Medical Center, Durham, NC
Decrease of p38 MAPK Activation in Myeloproliferative Disorders
M Shahjahan, CH Dunphy, N Singhal, L Garza, Y Zu, C Chang - The Methodist Hospital, Houston, TX; University of North Carolina, Chapel Hill, NC
Effects of Rituximab on the Immunophenotype of Benign B-cell Precursors: Implications for Flow Cytometric Minimal Residual Disease Detection in Precursor B-Acute Lymphoblastic Leukemia
K Siami, S Awagu, DG Cooper, DA Thomas, Y Huh, D Jones, W Chen, JL Jorgensen - UTMDACC, Houston, TX
ZAP70 Expression In CLL-A Correlative Study Using Flow Cytometry, Immunocytochemistry And Western Blot Analysis
GW Slack, J Wizniak, L Dabbagh, X Shi, R Lai - University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada
Plasma Cell Dyscrasias: Flow Cytometric Vs Histologic Detection, How Do They Compare?
JH Smouse, DM Dorfman, J Vergilio - Brigham and Women's Hospital, Boston, MA
Downregulation of MCl-1 and Induction of Apoptosis in Mantle Cell Lymphoma by Flavopiridol (Pan CDK4 Inhibitor)
G Venkataraman, T Maududi, F OzPuyan, HI Bahar, J Qin, KF Izban, S Alkan - Loyola University Medical Center, Maywood, IL; Elmhurst Memorial Hospital, Elmhurst, IL
Utility Of PAX-5 Immunohistochemistry To Assess Bone Marrow Involvement By B-Cell Malignancy In The Setting Of Anti-CD20 Therapy And Its Expression In A Variety Of Bone Marrow Disorders.
DM Vlasoff, WG Morice, JD Hoyer - Mayo Clinic, Rochester, MN
Comprehensive Proteomic Analysis of Reed-Sternberg Cells
JC Wallentine, KK Kim, C Seiler, DK Crockett, SR Tripp, KSJ Elenitoba-Johnson, MS Lim - University of Utah School of Medicine, ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT
Significance of Cytogenetic and Immunophenotypic Findings in Patients with Acute Myeloid Leukemia Evolving from Myelodysplastic Syndrome
JS Warrington, MJ Routbort, PJ Buckley, JZ Gong, BK Goodman, AS Lagoo - Duke University Medical Center, Durham, NC